Report
Debbie Wang
EUR 100.00 For Business Accounts Only

Quest Diagnostics Delivers Strong Volume Growth in 2Q; Our FVE Remains Unchanged

Quest Diagnostics’ solid second-quarter performance generally fell in line with our expectations, and the firm remains on track with our projections for the year. Our fair value estimate is unchanged. We were particularly pleased to see organic quarterly volume growth up 2.9%. This continues the robust volume growth we saw in the first quarter and puts volume in 2019 on firm footing compared with 2018. We view these volume gains as a positive factor reinforcing Quest’s narrow economic moat, whic...
Underlying
Quest Diagnostics Incorporated

Quest Diagnostics provides diagnostic information services. The company's diagnostic information segment provides information based on the menu of routine, non-routine and clinical testing and anatomic pathology testing, and other diagnostic information services. The company's testing capabilities, includes services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and provides tests in several fields, including endocrinology, immunology, neurology and oncology. The company's diagnostic solutions provides risk assessment services for the life insurance industry, as well as provides healthcare organizations and clinicians health information technology solutions.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch